Focal Laser Photocoagulation and Photodynamic Therapy for Lupus Choroidopathy.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 412, doi. 10.1177/0961203314522339
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 2014 AND VI 23 AND IP 4
Results: 16
1
2
Plasma CD147 reflects histological features in patients with lupus nephritis.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 342, doi. 10.1177/0961203314520840
- By:
- Publication type:
- Article
3
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 360, doi. 10.1177/0961203314520838
- By:
- Publication type:
- Article
4
Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 421, doi. 10.1177/0961203313520340
- By:
- Publication type:
- Article
5
Serum milk fat globule epidermal growth factor 8 elevation may subdivide systemic lupus erythematosus into two pathophysiologically distinct subsets.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 386, doi. 10.1177/0961203314523870
- By:
- Publication type:
- Article
6
Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janiero, October 2013.
- Published in:
- 2014
- By:
- Publication type:
- Speech
7
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 407, doi. 10.1177/0961203314522333
- By:
- Publication type:
- Article
8
Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies.
- Published in:
- 2014
- By:
- Publication type:
- Proceeding
9
Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 353, doi. 10.1177/0961203314522335
- By:
- Publication type:
- Article
10
Association of extended interleukin-10 promoter haplotypes with disease susceptibility and manifestations in German patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 378, doi. 10.1177/0961203314522334
- By:
- Publication type:
- Article
11
Successful application of belimumab in two patients with systemic lupus erythematosus experiencing a flare during tocilizumab treatment.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 428, doi. 10.1177/0961203314520844
- By:
- Publication type:
- Article
12
Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 370, doi. 10.1177/0961203314520843
- By:
- Publication type:
- Article
13
Tomography and blood vessels in Hughes syndrome.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 337, doi. 10.1177/0961203313520061
- By:
- Publication type:
- Article
14
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 417, doi. 10.1177/0961203313520059
- By:
- Publication type:
- Article
15
A descriptive study of the factors associated with damage in Malaysian patients with lupus nephritis.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 436, doi. 10.1177/0961203313518624
- By:
- Publication type:
- Article
16
Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010.
- Published in:
- Lupus, 2014, v. 23, n. 4, p. 431, doi. 10.1177/0961203313517015
- By:
- Publication type:
- Article